Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure

Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure - Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026209

Enrollment

140

Registered

2017-03-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (a)Patients whose main or deputy name of disease are chronic heart failure or healthy control group who are willing to take part in this study (b)Age more than 20 years and under 85 years (c)Patients or control group from whom a written informed consent was obtained

Exclusion criteria

Exclusion criteria: (a)Patients received investigational new drugs within six months (b)Patients with non-cardiac or non-renal disease(such as a malignancy, serious infection, and so on) and their prognoses are less than one year (c)Patients with renal insufficiency (eGFR< 30 ml/min/1.73m2) or on maintenance dialysis (d)Patients who is not suitable to this study due to medical reasons

Design outcomes

Primary

Measure	Time frame
plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP)	—

Countries

Japan

Contacts

Public ContactNorifumi Kawakita

Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences Cardiovascular Medicine

rm3ta6@bma.biglobe.ne.jp086-235-7351

Outcome results